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Abstract
The electrophysiological and pharmacological 
properties of Ca2+ current (lCa) were determined by 
the whole-cell configuration of the patch-clamp 
technique in smooth muscle cells from human 
umbilical artery. Using 5 mM extracellular Ca2+, 
depolarizing step pulses from -60 to 50 mV from a 
holding membrane potential of-80 mV evoked an lCa 
which activated at membrane potentials more positive 
than -50 mV and exhibited a maximum current density 
in a range of 10-20 mV. Steady-state inactivation 
protocols using a Vtestof 10 mV gave a voltage at one- 
half inactivation and a slope factor of -35.6 mV and 
9.5 mV, respectively. Nifedipine (1 pM), an L-type Ca2+ 
channels antagonist, completely inhibited lCa, while the 
L-type Ca2+ channels agonist Bay-K 8644 (1 pM) 
significantly increased lCa amplitude. Moreover, the 
selective blocker of P-/Q-type Ca2+channels ro- 
agatoxin IVA partially blocked lCa (about 40 % inhibition 
at +20 mV by 20 nM). These pharmacological results 
suggest that L- and P-/Q-type Ca2+ channels, both 
nifedipine-sensitive, underlie the lCa registered using 
low extracellular Ca2+. The presence of the P-/Q-type 
Ca2+ channels was confirmed by immunoblot analysis. 
When lCawas recorded in a high concentration (30 
mM) of extracellular Ca2+ or Ba2+ as current carrier, it 
was evident the presence of a nifedipine-insensitive 
component which completely inactivated during the 
course of the voltage-step (75 ms) at all potentials 
tested, and was blocked by the T-type Ca2+ channels 
blocker mibefradil (10 pM). Summarizing, this work 
shows for the first time the electrophysiological and 
pharmacological properties of voltage-activated Ca2+ 
currents in human umbilical artery smooth muscle 
cells.
Copyright © 2007 S. Karger AG, Basel
Introduction
Vascular smooth muscle tone is regulated by different 
mechanisms. One of the most important is the degree of 
Ca2+ permeability of the plasma membrane which is 
determined by the presence of several Ca2+ entry 
pathways. It has been demonstrated that low- and high- 
voltage-activated Ca2+ channels (LVA and HVA, 
KARGER
Fax +41 61 306 12 34
E-Mail karger@karger.ch 
www.karger.com
© 2007 S. Karger AG, Basel
1015-8987/07/0204-0055S23.50/0
Accessible online at:
www.karger.com/cpb
Verónica Milesi
Cátedra de Fisiología, Dpt de Ciencias Biológicas, Facultad de Ciencias Exactas 
Universidad Nacional de La Plata, calles 47 y 115, La Plata 1900 (Argentina) 
Tel. +54 221-425 0497 ext. 48, Fax +54 221-489 0354
E-Mail veronica@biol.unlp.edu.ar
respectively) are expressed in different kinds of vascular 
smooth muscle cells. Different pore-forming a subunits 
have been cloned and expressed in heterologous systems 
observing that alternative splicing exons and coexpression 
with a28, y and P subunits, play important regulatory roles 
in the properties of functional Ca2+ channels in native 
cells [1,2],
Among the HVA Ca2+ channels family, the 
dihydropyridine-sensitive L-type Ca2+ channels are, by 
far, the most studied [3-6], However, other members of 
the HVA Ca2+ channels family, the P-/Q-type Ca2+ 
channels, have been recently described in rat vascular 
smooth muscle cells, having a functional role in renal 
afferent arterioles [7]. Regarding the LVA Ca2+channels, 
the presence of the T-type Ca2+ channels has been 
reported in several vessels [4, 8-11],
The study of the presence of different types of 
voltage-activated Ca2+ channels, and their 
electrophysiological and pharmacological properties, in 
human vascular smooth muscle cells is important to 
increase the knowledge of Ca2+ pathways that could be 
involved in contractile responses induced by changes in 
cell membrane potential or other vasoactive stimuli that 
can affect their activity. Nevertheless, the vast majority 
of reports in the literature regarding Ca2+ channels involve 
non-human vessels or cultured cells, and the information 
about human vascular smooth muscle is scant. In 
particular, P-/Q-type Ca2+ channels have not yet been 
described, to the best of our knowledge, in human vessels.
We focused our attention in Ca2+ channels of the 
human umbilical artery (HUA). In this vessel, there are 
some reports showing the effects of Ca2+ channels 
antagonist on arterial contractility [12, 13], and we have 
also reported that nifedipine induced a complete relaxation 
of HUA rings contraction induced by a depolarizing high 
K+ solution [14], However, there is no information 
regarding neither the electrophysiological characteristics 
nor the molecular structure of voltage-activated Ca2+ 
channels expressed in this artery.
In this work, we show for the first time the 
electrophysiological and pharmacological properties of 
voltage-activated whole-cell Ca2+ current in HUA smooth 
muscle cells, which suggest that L, P-/Q- and T-type Ca2+ 
channels are present is this vessel. Additionally, the 
presence of the a subunit of the P-/Q-type Ca2+channels 
was confirmed by immunoblot analysis. U- and P-/Q-type 
Ca2+ channels, both sensitive to nifedipine 1 pM, underlie 
the majority of voltage-activated calcium current recorded 
with extracellular solutions containing 5 mM of Ca2+, 
whereas the contribution of T-type Ca2+ channels could 
be evidenced using a high extracellular Ca2+ or Ba2+ 
concentration.
Materials and Methods
Cell isolation procedure
Umbilical cords obtained after vaginal and cesarean 
delivery were placed in saline solution containing (in mM): 130 
NaCl, 4.7 KC1,1.17 KH2PO4,1.16 Mg SO4,24 NaHCO3,2.5 CaCl2, 
pH 7.4 at 4°C and immediately transported to our laboratory 
and stored at 4°C. The arteries were dissected from the 
Wharton's jelly just before the cell isolation procedure. HUA 
smooth muscle cells were obtained by a method based on the 
one described by Klöckner [15] and later modified in our 
laboratory in order to diminish the enzyme content in the 
dissociation medium (DM) [14], Briefly, a segment of HUA was 
cleaned of any residual connective tissue, cut in small strips 
and placed for 15 min in a DM containing (in mM): 140 NaCl, 5 
KH2PO4, 5 MgCl2, 20 glucose, 5 HEPES, pH was adjusted to 7.4 
with NaOH. The strips were then placed in DM with 2 mg/ml 
collagenase type I during 25 min, with gentle agitation, at 35°C. 
After the incubation period the strips were washed with DM 
and single HUA smooth muscle cells were obtained by a gentle 
dispersion of the treated tissue using a Pasteur pipette. The 
remaining tissue and the supernatant containing isolated cells 
were stored at room temperature (~20°C) until used.
Patch-clamp recordings
HUA smooth muscle cells were allowed to settle onto the 
coverglass bottom of a 0.5 ml experimental chamber. The cells 
were observed with a mechanically stabilized, inverted 
microscope (Telaval 3, Carl Zeiss, Jena, Germany) equipped 
with a 40X objective lens. The chamber was perfused for 15 
min, at 0.5 ml.min-1 by gravity, with the extracellular saline 
solution (ESS, see composition later) before the patch-clamp 
experiment was started. Application of test solutions was 
performed through a multibarreled pipette positioned close to 
the cell investigated. After each experiment on a single cell, the 
experimental chamber was replaced by another one containing 
a new sample of cells. Only well-relaxed, spindle-shaped smooth 
muscle cells were used for electrophysiological recordings. Data 
were collected within 4-6 h after cell isolation. All experiments 
were performed at room temperature (~20°C).
The standard tight-seal whole-cell configuration of the 
patch-clamp technique [16] was used. Glass pipettes were 
drawn from WPI PG52165-4 glass on a two-stage vertical 
micropipette puller (PP-83, Narishige Scientific Instrument 
Laboratories, Tokyo, Japan) and pipette resistance ranged from 
2 to 4 MQ measured in ESS. Ionic currents were measured with 
an Axopatch 200A amplifier (Axon Instruments, Foster City, 
CA). Whole-cell currents were filtered at 2 kHz, digitized 
(Digidata 1200 Axon Instruments, Foster City, CA) at a sample 
frequency of 100 kHz, except in the case of the steady-state 
inactivation protocols in which the sampling frequency was 20 
kHz. The experimental recordings were stored on a computer
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Fig. 1. Whole-cell Ca2+ current (ICa) in HUA smooth muscle cells. A: superimposed representative recordings of I elicited by 
voltage pulses between -60 and 50 mV from a membrane holding potential (HP) of -80 mV. B: mean I-V curve obtained from n=50 
cells. C: mean I-V curves obtained using a membrane HP of -80 mV or -40 mV (n=9 cells); * indicates statistical difference from the 
current value obtained using a membrane HP of -80 mV (p<0.05).
hard disk for later analysis. Whole-cell capacitance was 
compensated electronically in most cells. In all cells whole-cell 
current was controlled applying test voltage steps during a 
short stabilization period discarding those in which the current 
amplitude did not remain constant with time.
Solutions
The ESS used for recording whole-cell ionic currents 
contained (in mM): 116 NaCl, 4.7 KC1, 5 CaCl2, 6 glucose, 5 
HEPES, 10 tetraethylammonium (TEA); pH was adjusted to 7.4 
with NaOH. In some experiments we used a CaCl2 concentration 
of 30 mM while NaCl was adequately diminished to maintain 
the solution osmolarity. An identical ESS but containing 30 
mM of BaCl2 instead of CaCl2 was also used.
The composition of the intracellular pipette solution (IPS) 
was (in mM): 120 CsCl, 5 Na2ATP, 1 MgCl2, 10 glucose, 10 
EGTA, 20 HEPES; pH was adjusted to 7.3 with CsOH.
SDS-PAGE and Immunoblot Analysis
Human umbilical arteries were isolated as described above. 
Endothelial layer was eliminated mechanically. Smooth muscle 
proteins were extracted with 20 mM Tris-HCl, 8 M Urea, 1% 
SDS, pH 7.5 and were resolved by sodium dodecylsulphate­
polyacrylamide gel (6%) electrophoresis (SDS-PAGE) followed 
by transfer to nitrocellulose membranes (Schleicher & Schuell 
Bioscience, Inc., USA). The membranes were stained with 
Ponceau S to monitor protein loading prior to immunodetection. 
Nitrocellulose membranes were first blocked with 3 % (w/v) 
non-fat milk for 1 h at 37°C. After several washes, the 
membranes were incubated overnight at 4°C with rabbit 
antibodies against alA subunit of the P-/Q-type Ca2+ channel 
at a dilution of 1:500 (Alomone Labs, Jerusalem, Israel). 
Subsequently, the membranes were incubated with horseradish- 
conjugated anti-rabbit secondary antibody, and immunoreactive 
signals were detected with luminol followed by an exposure to 
X-ray film (Kodak, USA). The experiments were repeated after 
blocking the primary antibodies by pretreatment with a control 
peptide provided by the manufacturer.
Reagents
Collagenase type I (used for cell isolation), ethylene 
glycol-bis(P-aminoethyl ether) N,N,N’,N’,-tetraacetic acid 
(EGTA), CsCl, Na2ATP, nifedipine, Ponceau S and luminol were 
purchased from Sigma-Aldrich (St Louis, MS, USA), and (±) 
Bay-K 8644 and co -agatoxin IVA were purchased from Alomone 
Labs. Ltd. (Jerusalem, Israel). All other reagents were of 
analytical grade and purchased from local vendors. Stock 
solutions of nifedipine and Bay-K 8644 were prepared in DMSO 
while co-agatoxin IVA and mibefradil were dissolved in water. 
Fresh aliquots of stocks solutions were added to the different 
extracellular solutions on the day of the experiment. The final 
maximal concentration of DMSO in the solutions used for 
current measurements was very low (0.05%), and data from the 
literature show that even greater concentrations (0.1%) of 
DMSO did not affect calcium currents [17, 18],
Statistics
The results are expressed as means ± SEM. Paired or 
unpaired Student’s t-tests were used to establish statistically 
significant differences between two groups. The level of 
statistically significant differences was set to p<0.05.
Ethical considerations
The collection of umbilical cords was authorized by the 
Ethics Committee of the Hospital General Interzonal de Agudos 
Oral. San Martin of La Plata, and the patients were informed 
that the umbilical arteries would be used for scientific research. 
The experimental protocols were approved by the Scientific 
Committee of our institution.
Results
To study the presence of voltage-activated Ca2+ 
channels in freshly dispersed smooth muscle cells from 
HUA, whole-cell currents were recorded using a high
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Fig. 2. Activation and inactivation properties of I A: representative recordings of I with the fit curves superimposed, and the 
relationships between mean values of t . and t. plotted against membrane potential (V ) (n=34-36 for each value). B: Lr activation inactivation r o r v m7 ' Ca
registered by application of steady-state inactivation protocols using a V|csl of 10 mV (n=9 cells) and its corresponding h-curve.
Cs IPS, and 5 niM Ca2 in the ESS. Figure 1A shows 
typical whole-cell Ca2 currents (ICa) evoked by a voltage­
clamp protocol applying 10 mV increase voltage-steps 
from -60 to 50 mV using a membrane holding potential 
(HP) of -80 mV. The mean peak current-voltage (I-V) 
relationship obtained from 50 smooth muscle cells of 18 
different HUA samples is depicted in figure IB. ICa begins 
to activate at membrane potential (Vm) values more 
positive than -50 mV (range -40 to -30 mV among 
different cells), it presents a maximum current density at 
a value between 10 and 20 mV, and an extrapolated 
reversal potential of approximately 60 mV. When I-V 
curves were obtained using a more depolarized membrane 
HP (-40 mV) the threshold of activation for ICa was around 
-20 mV, its maximum at membrane potentials between 
10 and 20 mV, and its peak amplitude was significantly 
lower at all Vm tested compared to 1-V curves obtained 
in the same cells using a membrane HP of -80 mV 
(figure 1C).
The lCa evoked by the different voltage-steps were 
well fitted with a double exponential function (Aje’**’^' 
activation _|_ ^2g-(t-k)/Tinactivation _|_ Q obtaining tWO time 
parameters (r t f and t t f Representative of 
activation and decay of inactivation kinetics, respectively. 
Figure 2A shows typical examples and the relationships 
between these parameters and the Vm, where it is possible 
to observe that while t . . decreased when V became activation m
more depolarized, t. . . was voltage-independent up 
to 0 mV, while finally increased between 0 and 40 mV.
Steady-state inactivation of ICa was determined using 
a standard two-pulse protocol, with a membrane HP of - 
80 mV and a test potential (Vtest) of 10 mV. 4-seconds- 
conditioning pulses from -100 mV to 10 mV (10 mV steps 
at 0.1 Hz) were applied before the test potential to assess 
ICa availability. Peak ICa amplitude elicited by the test 
potential, expressed as a proportion of the maximal lCa 
recorded, was plotted against the value of the conditioning 
potentials. A steady-state inactivation curve was obtained
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Fig. 3. Effect of nifedipine and Bay-K 8644 on I A: Left panel: Typical recordings of I elicited by a voltage step from a 
membrane HP of -80 mV to 20 mV in (a) control conditions (3 superimposed recordings); after 15 s (b), 45 s (c) and 105 s (d) of 
addition of 1 itM nifedipine; and after partial wash of nifedipine effects (e). Right panel: typical time course of blockade of peak 
I by 1 pM nifedipine; the points (a) to (e) correspond to those shown in the left panel. B: mean I-V relationships in control 
conditions and after stable effect of 1 itM nifedipine (n=7 cells). C: Typical recordings of I elicited by a voltage step from a 
membrane HP of-80 mV to 20 mV before and after Bay-K 8644 effect (superimposed), and the corresponding Bay-K 8644- induced 
I obtained by current subtraction. D: Mean I-V curves for control I and after enhancement of the current by Bay-K 8644 (n=6 
cells). In B and D, * indicates statistical difference from the control value (p<0.05).
by fitting mean fraction current values with a standard 
Boltzmann equation: h={ 1 + exp [(Vm - V1/2)/k] }_1, where 
h is the fraction of current inactivated, V is the membrane 
potential, V1/2 is the voltage at one-half inactivation and k 
is the slope factor. The V1/2 and k values obtained were 
-35.6 mV and 9.5 mV, respectively (Figure 2B), which is 
in agreement with the fact reported above (figure 1C) 
that when a membrane HP of -40 mV was used the peak 
currents obtained were about half of those registered using 
a membrane HP of -80 mV.
Nifedipine (1 pM), the commonly used L-type Ca2+ 
channels antagonist, rapidly induced a complete inhibition 
of ICa (figure 3 A and B), while the L-type Ca2+ channel 
agonist Bay-K 8644 (1 pM) significantly increased ICa 
amplitude. Although nifedipine, at a concentration 
commonly used as L-type Ca2+ channel blocker in vascular 
smooth muscle cells, had a complete inhibitory effect on 
total Ca2+ current, suggesting that L-type Ca2+ channels 
underlie the total current, other members of the HVA 
Ca2+ channels family, in particular the P-/Q-type, have 
also been shown to be sensitive to nifedipine in the same 
range of concentration as L-type Ca2+ channels in other 
kinds of cells [19, 20], Since P-/Q-type Ca2+channels, 
extensively described in neurons, have been found only 
recently in vascular smooth muscle cells [7], we tested 
the effect of o-agatoxin IVA, the selective blocker of P- 
/Q-type Ca2+ channels, on ICa in HUA smooth muscle 
cells observing that it was partially blocked: at 20 mV 
about 25% of the ICa was inhibited by 10 nM of toxin, and 
the inhibitory effect was higher for toxin concentrations 
of 20 or 100 nM (figure 4). The effect was reversible in 
most cells when the toxin was used at 10 nM, while at 20
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Fig. 4. Effect of co- 
agatoxin IVA on ICa and 
expression of P-/Q- 
type C'a- channel in 
human umbilical artery. 
A: Typical recordings 
of lCa elicited by a 
voltage step from a 
membrane HP of-80 mV 
to 20 mV in control 
conditions and after a 
stable inhibition by 100 
nM ra-agatoxin IVA. B: 
mean I-V curves 
obtained for control 
conditions and after 
stable effect of 100 nM 
ro-agatoxin IVA (n=5 
cells); * indicates 
statistical difference 
from the control value 
(p<0.05). C: Bars re­
present average ± SEM 
values of % of inhi­
bition of ICa (at +20 mV) 
by o-agatoxin IVA at 
three different concen­
trations: 10 nM (n=5), 
20 nM (n=10) and 100 
nM (n=5). * indicates 
statistical difference 
from zero (p<0.05). D: 
Immunoblot analysis 
with a specific antibody 
against the alA subunit of the P-/Q-type Ca2+ channel on a sodium dodecylsulphate-polyacrylamide gel (6 %) electrophoresis 
(SDS-PAGE) of proteins extracted from human umbilical artery smooth muscle cells. Lane 1: antibody, lane 2: antibody pretreated 
with control peptide provided by the manufacturer. Molecular masses in kilodaltons are given on the left.
A B
or 100 nM only in 4 out of 15 cells a partial wash could be 
observed.
To verify by a non-phartnacological approach that 
P/Q-type Ca21 channel was present in human umbilical 
artery, immunoblots were performed using antibodies 
specific for mouse otl A subunit of the P-/Q-type 
Ca2+channel. Immunoblots of umbilical artery smooth 
muscle protein extracts gave rise to one band of the 
expected size [7], which did not appear when the antibody 
was pretreated with the control peptide provided by the 
manufacturer (Figure 4D). Other proteins present in the 
extract were not recognized by the antibody, therefore 
reaction conditions were specific. The immunoblots were 
repeated a total of three times, always with the same 
results. Moreover, similar results were also obtained (data 
not shown) using the same protocol with primary
antibodies purchased from two other chemical companies 
(Sigma-Aldrich, St Louis, USA; and Santa Cruz 
Biotechnology Inc., Santa Cruz, USA, which required an 
anti-goat secondary antibody).
Regarding the contribution of a LVA T-type Ca2+ 
current (ICaT) to total ICa in HUA smooth muscle cells, in 
the present recording conditions (5 rnM extracellular Ca2+) 
we did not observe a T-type component in ICa neither by 
changing the membrane HP nor after nifedipine addition. 
First, and as it was shown in figure 1C, the change in 
membrane HP from -80 to -40 mV produced a decrease 
of the ICa elicited by all the membrane potentials tested, 
preventing the observation of a selective effect of 
membrane HP on a putative LVA Ca2 current; and 
second, nifedipine completely blocked ICa.
However, Smirnov & Aaronson [4] found that in
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Fig. 5. Whole-cell currents recorded with high (30 mM) Ca2+ o Ba2+ extracellular concentration. A: Superimposed representative 
recordings of whole-cell currents elicited by voltage pulses between -60 and 50 mV from a membrane HP of -80 mV with Ba2+ as 
ion carrier (IBa, left panel) or Ca2+ (I middle panel), and mean density I-V relationships obtained in such conditions (right panel, 
n=15 cells for IBa and n=13 cells for ICa); * indicates statistical difference from the values obtained for IBa(p<0.05). B: Typical 
recordings of IBa elicited from a membrane HP of -80 mV by voltage steps to -20 and 20 mV and the mean values of and
motivation plotted against Vm obtained in control conditions (left panel) and after a stable effect of 1 liM nifedipine (middle panel).
In the right panel mean I-V curves found for IBain control conditions (n=l 1 cells), after the effect of 1 liM nifedipine (n=8) and in 
presence of 1 liM nifedipine plus 10 liM of mibefradil (n=8 cells) are shown. * indicates statistical difference from the values 
obtained in control conditions (p<0.05).
human mesenteric artery cells there was a relatively small 
ICaT which proved difficult to detect when cells were 
superfused with solutions containing low millimolar 
concentrations of divalent cation charge carrier, so we 
also tested the pharmacological profile of ICausing a high 
concentration (30 mM) of Ca2+ or Ba2+ in the extracellular 
solution with the aim of increasing the magnitude of ICaT, 
if it were present. Figure 5A shows typical examples of 
IBa and ICaand the I-V relationships obtained by the same 
voltage-protocol described in figure 1 but now using a 
high Ca2+ or Ba2+ concentration. IBawas significantly 
higher than whole-cell currents recorded in high Ca2+ in 
a range of membrane potentials between 10 to 30 mV, 
and inactivation time decay was slower than in high Ca2+ 
(t t t mean values at 20 mV: 160.6 ±46.2 ms for I„ ,v inactivation Ba’
n=9; and 24.7 ± 2.6 ms for ICa, n=ll). Addition of 1 pM 
nifedipine partially inhibited IBa, leaving a current which 
inactivated completely during the time of the voltage step 
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(75 ms) at all Vm tested, and exhibited maximal amplitudes 
at Vm in the range of 0 to 10 mV (figure 5B). This 
nifedipine-insensitive current recorded in Ba2+ was 
completely blocked by 10 pM of mibefradil (figure 5B) in 
a reversible manner. Similar effects were observed on 
ICa recorded in high extracellular Ca2+ concentration, 
although the maximum value of its peak I-V relationship 
appeared at a more hyperpolarized Vm range (-20 mV to 
-10 mV, data not shown). The mean t t t andr t t’ ' activation inactivation
values were obtained for L in control conditions and inBa
presence of nifedipine, fitting the respective recordings 
with a double exponential function as done before. The 
values obtained were plotted as a function of the Vm and 
are shown in figure 5B.
Discussion
This study presents for the first time the 
electrophysiological and pharmacological characteristics 
of voltage-activated Ca2+ current in freshly isolated smooth 
muscle cells from HUA. The obtained results show that 
L-, P-/Q- and T-type Ca2+ channels are present in this 
vessel, constituting different voltage-activated Ca2+ 
pathways. Although L- and, to some extent, T- type Ca2+ 
channels were expected to appear, the presence of P-/ 
Q-type Ca2+ channels is an important novelty, since, to 
the best of our knowledge, there are no previous reports 
of these channels in human vascular smooth muscle.
The electrophysiological and pharmacological results 
suggest that in HUA U- and P-/Q-type Ca2+ channels 
underlie the majority of ICa recorded with extracellular 
solutions containing 5 mM of Ca2+, whereas the 
contribution of T-type Ca2+ channels could be evidenced 
using a high extracellular Ca2+or Ba2+ concentration. As 
nifedipine (1 pM) completely blocked ICa, while co-agatoxin 
IVA, the selective blocker of P-/Q-type Ca2+ channels, 
inhibited about 40% of total current, we can suggest that 
U- and P-/Q-type Ca2+ channels, both sensitive to 
dihydropyridines, elicited the total ICa. Dihydropyridine­
sensitive P-/Q-type Ca2+ channels have been observed 
in other cells, such as rat melanotropic cells [19], and rat 
neurons [20], Moreover, Hansen and coworkers [7] 
clearly described in a recent paper the presence and the 
functional role ofP-/Q-type Ca2+channels in rat vascular 
smooth muscle, and they discussed the fact that if 
dihydropyridines are able to inhibit P-/Q-type Ca2+ 
channels, there exists the possibility that the role of U- 
type Ca2+ channels has been overestimated and, as they 
indicate, the effects of therapeutic concentrations of 
dihydropyridines could involve blockage of both types of 
Ca2+channels. In agreement with this idea, our results 
show that in HUA smooth muscle cells nifedipine, used 
at a concentration commonly used to demonstrate the 
presence of U-type Ca2+ channels, blocked the whole of 
ICa, masking the presence of other types of channels, as 
the P-/Q-type, which were afterwards put in evidence 
using a specific toxin and whose expression was 
confirmed by immunoblotting. This could clearly lead to 
an overestimation of the role of U-type channels in this 
vessel.
When the concentration of divalent ion carrier was 
increased in the extracellular solution, it was possible to 
put in evidence a nifedipine-insensitive ICa, as other authors 
have reported in human vascular smooth muscle cells 
[4], which was completely blocked by 10 pM mibefradil. 
This current, likely a T-type Ca2+ current, is detectable at 
Vm positive to -50 mV and the maximum peak current 
variably lies between -20 and 10 mV depending on the 
ion current carrier. The electrophysiological characteristics 
of this ICa share some of the properties described in the 
literature for T-type Ca2+ currents in vascular and non- 
vascular smooth muscle cells [11]. In particular, the 
activation and inactivation parameters of this ICa were in 
the range of values described in the literature for T-type 
currents registered in arterial smooth muscle cells where 
generally the presence of a tiny UVA Ca2+ current has 
been reported [11].
The results obtained working at high extracellular 
Ca2+ or Ba2+ concentration, not only allowed us to observe 
a T-type Ca2+ current component, but were also useful to 
put in evidence some characteristics of HVA Ca2+ 
channels. The comparison of I-V curves in Ca2+ and Ba2+ 
showed that the current amplitude in Ba2+ was significantly 
higher than that in Ca2+ only at membrane potentials 
positive to 0 mV, the range of membrane potentials where 
the contribution of HVA Ca2+ channels is more important. 
This result is in accordance with the Ca2+ and Ba2+ 
permeability properties described for T- and U-type Ca2+ 
channels, namely, that they exhibit the same permeability 
to Ca2+ and are more permeable to Ba2+than Ca2+, 
respectively [11, 21], The decay of inactivation in Ba2+ 
measured at 20 mV was much slower than in Ca2+, 
suggesting the presence of a Ca2+ dependent-inactivation, 
as has been several times reported for U-type Ca2+ 
channels in different types of cells, and for P-/Q-type 
Ca2+ channels, at least in neurons [22] and chromaffin 
cells [23],
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Physiological relevance of these results
As voltage-activated Ca2 channels represent 
important pathways for Ca2+ influx in smooth muscle cells, 
and we are interested in the mechanisms of intracellular 
Ca2+ regulation in human umbilical artery, we first studied 
the properties of these channels with the aim of 
characterizing them to further study their role in the 
regulation of the contractile state of this vessel. Several 
contractile evidences have been reported with respect to 
dihydropyridine effects on HUA. Belford and coworkers 
[12] have reported that dihydropyridines were potent 
vasodilators of HUA rings precontracted with high-K 
solutions, nifedipine being the most potent (it reached a 
maximum effect at a concentration of 1 pM). Nifedipine 
at 3 pM completely inhibited bupivacaine-induced twitches 
in HUA, while a tonic tone persisted in its presence [13], 
Moreover, Gopalakrishnan and coworkers [24] showed 
that Bay-K 8644 caused a dose-dependent increase of 
tone in the HUA. Our results are in agreement with these 
findings, because recording in a low Ca2 concentration 
(not so far from the physiological one) 1 pM nifedipine 
completely blocked, and Bay-K 8644 significantly 
increased, the macroscopic voltage-activated Ca2 current 
in isolated smooth muscle cells from HUA. However, 
our results also show that nifedipine at 1 pM is able to 
block two different populations of Ca2+ channels, namely, 
U- and P-/Q-type Ca2 channels. Data regarding the 
functional role of P-/Q-type Ca2 channels in vascular 
smooth muscle cells are scant. Hansen and coworkers 
[7] have demonstrated in rat renal afferent arterioles that 
co -agatoxin IVA induced a partial blocking effect on total 
whole-cell Ca2 current and abolished high K -induced 
contractions. It would be interesting to investigate in the 
future if these subtypes of HVA Ca2 channels in HUA 
smooth muscle cells selectively participate in the regulation 
of different mechanisms that regulate the contractile state 
of this vessel.
In this work we show that in HUA smooth muscle 
cells a T-type Ca2+ current sensitive to mibefradil could 
be elicited by depolarization of membrane potential, 
although it was put in evidence in a high-Ca2 or high- 
Ba2+ extracellular solution, a condition, nevertheless, used 
in several reports of Ca2 channels in vascular smooth 
muscle [11]. At present, we can only speculate about 
their importance in HUA smooth muscle cells and further 
studies will be conducted to establish their possible function 
in this vessel. Up to now, T-type Ca2 channels have been 
implicated in different roles in vascular smooth muscle, 
for instance, control of cell proliferation in human 
pulmonary artery [25], regulation of myogenic tone in rat 
skeletal muscle resistance arteries [10], and serving as 
Ca2+ entry routes required for activation of high 
conductance Ca2 -activated potassium channels (BKCa) 
in mouse coronary arteries [26],
Taken together, our results open a field of future 
research about the role of the different Ca2+channels in 
the regulation of contractility of HUA and consequently 
in the regulation of feto-placental circulation. They could 
constitute different targets for endogenous or exogenous 
agonists that modulate the intracellular Ca2+ concentration 
and hence the vessel tone.
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